We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.
CEMI

Delisted

CEMI was delisted on the 27th of April, 2023.

Back to rankings

77 hedge funds and large institutions have $39.8M invested in Chembio diagnostics, Inc. in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

31% more funds holding

Funds holding: 59 → 77 (+18)

30% more capital invested

Capital invested by funds: $30.5M → $39.8M (+$9.29M)

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

44% less call options, than puts

Call options by funds: $1.39M | Put options by funds: $2.49M

Holders
77
Holders Change
+18
Holders Change %
+30.51%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
22
Reduced
17
Closed
6
Calls
$1.39M
Puts
$2.49M
Net Calls
-$1.09M
Net Calls Change
-$1.19M

Top Buyers

Rank Fund Capital Flow
1
FA
Friess Associates
Delaware
+$2.87M
2
IC
Ikarian Capital
Texas
+$1.13M
3
Goldman Sachs
Goldman Sachs
New York
+$1.03M
4
SMH
Sanders Morris Harris
Texas
+$948K
5
Marshall Wace
Marshall Wace
United Kingdom
+$914K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.38M
2
N
Nuveen
North Carolina
-$564K
3
BCM
Bayesian Capital Management
New York
-$279K
4
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$220K
5
SC
Sculptor Capital
New York
-$167K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$5.7M +$156K +30,110 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.93M -$1.38M -267,285 -20%
SBH
3
Segall Bryant & Hamill
Illinois
$3.35M +$402K +77,874 +12%
FA
4
Friess Associates
Delaware
$2.64M +$2.87M +555,000 New
RA
5
Royce & Associates
New York
$2.33M – – –
USPCM
6
Union Square Park Capital Management
New York
$1.9M +$2.07M +400,000 New
PM
7
Penbrook Management
New York
$1.63M +$6.71K +1,300 +0.4%
Northern Trust
8
Northern Trust
Illinois
$1.39M -$54.3K -10,507 -3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.26M +$130K +25,110 +10%
State Street
10
State Street
Massachusetts
$1.2M -$8.91K -1,726 -0.7%
IC
11
Ikarian Capital
Texas
$1.04M +$1.13M +219,109 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$1.03M +$672K +130,170 +151%
SMH
13
Sanders Morris Harris
Texas
$990K +$948K +183,584 New
Goldman Sachs
14
Goldman Sachs
New York
$950K +$1.03M +200,047 New
Marshall Wace
15
Marshall Wace
United Kingdom
$841K +$914K +176,981 New
PM
16
Precept Management
Texas
$713K +$775K +150,000 New
Ameriprise
17
Ameriprise
Minnesota
$521K +$69.1K +13,374 +14%
Squarepoint
18
Squarepoint
New York
$508K +$552K +106,886 New
PAWC
19
P.A.W. Capital
Connecticut
$475K +$516K +100,000 New
NFSG
20
Newbridge Financial Services Group
Florida
$349K +$380K +73,500 New
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$319K – – –
Bank of New York Mellon
22
Bank of New York Mellon
New York
$309K +$83K +16,072 +33%
Citadel Advisors
23
Citadel Advisors
Florida
$301K -$140K -27,049 -30%
Morgan Stanley
24
Morgan Stanley
New York
$301K +$84.4K +16,352 +35%
N
25
Nuveen
North Carolina
$300K -$564K -109,275 -63%
1
2 3 4

CEMI Hedge Fund Activity: Q4 2020 in Review

77 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2020, worth a combined $39.8M — up 30% from $30.5M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new CEMI positions and 6 closed out — a net gain of 19 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Friess Associates, opening a new position worth an estimated $2.87M. The largest seller was Vanguard Group, cutting an estimated $1.38M.

  • 77 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2020, up from 59 in Q3 2020.
  • Funds reported $39.8M of Chembio diagnostics, Inc. stock for Q4 2020, up 30% quarter-over-quarter.
  • 25 funds opened new Chembio diagnostics, Inc. positions in Q4 2020 and 6 closed out, a net change of +19 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q4 2020 was Friess Associates, an estimated $2.87M added.
  • The largest Chembio diagnostics, Inc. seller in Q4 2020 was Vanguard Group, an estimated $1.38M sold.

Based on aggregated 13F filings for Q4 2020.